In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Peptides are unproven as health aids. FDA may unleash them anyway BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times